1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Veerhealth Care Limited

Veerhealth Care Limited

BBSE:VEERHEALTH
49.00
INR
-0.11
(-0.22%)
0.76EPS
42.15P/E
649.75MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
2.15
0.96
1.57
1.38
3.71
4.29
8.38
7.56
6.89
6.61
6.58
8.3
16.05
26.66
Basic EPS, GAAP
0.02
0.04
0.01
0.02
0.1
0.11
0.23
0.27
-0.05
0.79
0.2
0.2
0.27
0.77
Free Cash Flow per Basic Share
-0.64
-2.69
-0.55
1.19
-1.28
-0.15
-1.79
0.36
0.16
-1.39
1.04
-2.15
-0.33
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
9.19
9.23
9.25
9.27
9.45
9.58
9.92
10.13
10.06
10.72
10.92
11.11
11.46
- -
Tangible Book Value per Share
9.19
9.23
9.25
9.27
9.45
9.58
9.92
10.13
10.06
10.72
10.92
11.11
11.46
- -
Basic Weighted Avg Shares
14
14
14
14
14
14
14
14
14
20
20
20
20
20
Sales/Revenue/Turnover
30
13
22
19
51
59
116
105
96
132
132
166
321
529
Operating Margin (%)
-15.61
-38.28
-9.49
-23
-6.18
6.33
3.06
-4.71
-11.36
1.4
1.67
0.52
4.75
5.73
Depreciation Expense
- -
1
1
2
3
3
3
5
5
6
7
9
13
14
Net Income, GAAP
- -
1
- -
- -
1
2
3
4
-1
16
4
4
5
15
Effective Tax Rate (%)
33.76
64.03
62.71
27.48
45.31
58.2
50.79
34.24
130.98
- -
68.32
36.97
56.75
38.65
Profit Margin (%)
0.86
4.27
0.41
1.19
2.67
2.66
2.74
3.62
-0.77
11.96
3.09
2.36
1.7
2.89
Working Capital
46
78
63
83
57
39
47
53
38
94
107
51
50
- -
LT Debt
- -
6
6
4
2
- -
20
14
- -
- -
- -
42
38
- -
Total Equity
127
128
128
129
131
133
138
140
140
214
218
222
229
- -
Return on Invested Capital (%)
0.2
-0.25
0.06
0.2
-1.61
0.36
1.15
-2.02
2.24
- -
0.32
0.51
1.91
- -
Return on Capital (%)
0.2
0.51
0.42
0.72
1.3
1.2
2.5
3.23
-0.59
- -
1.88
1.83
2.58
- -
Return on Common Equity (%)
0.2
0.44
0.07
0.18
1.06
1.2
2.35
2.73
-0.53
8.94
1.88
1.78
2.41
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
8
- -
LT Borrowings
- -
38
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
387
403
650

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
185
- -
Cash, Cash Equivalents & STI
- -
5
- -
Accounts Receivable, Net
- -
97
- -
Inventories
- -
44
- -
Total Current Liabilities
- -
134
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
8
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.89%
11.96%
3.17%
Free Cash Flow
-162.14%
-391.83%
-84.54%
Net Income, GAAP
-161.02%
-481.57%
39%
Sales/Revenue/Turnover
40.67%
29.72%
93.43%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
21
51
38
56
166
2026
45
40
73
168
321
2027
249
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.06
0.15
0.04
-0.05
0.2
2026
0.12
0.13
0.2
-0.18
0.27
2027
0.61
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Bhavin Sureshchandra Shah
Full Time Employees
64
Sector
Health technology
Industry
Pharmaceuticals: other
Address
629-A, Gazdar House Mumbai MH India 400002
IPO Date
Jan 2, 1995
Website
veerhealthcare.net
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Veerhealth Care Limited Veerhealth Care Limited (VEERHEALTH.BO) manufactures, markets, and trades research-based ayurvedic medicines, personal care, and oral care products in India. The company offers skincare products such as creams, lip balms, moisturizing lotions, face packs, rosewater, and scrubs; body care items including bodywash, bath salts, facewash, handwash, and soaps; haircare products comprising hair oils, shampoos, and conditioners; fragrances such as candles and body mists; healthcare solutions like pain relief oils, tablets, syrups, and sanitizers; oral care products including toothpastes; body and beard care items; gifting products; accessories; and combos such as haircare regimes and bath rituals. It also provides plastic bottles for industries including food, cosmetics, household cleaning, and pharmaceuticals, while selling products online and exporting to international markets including the United States. Incorporated in 1992 and headquartered in Mumbai, India, at 629-A Gazdar House, the company, formerly known as Niyati Leasing Limited, shifted from finance to pharmaceuticals in 2013 and entered cosmetic manufacturing in 2020. Recent developments include securing multiple export orders from a top US institutional supplier totaling over $350,000 in 2024 with expectations of monthly repeats; entering a strategic contract manufacturing agreement in 2025 with a leading Indian marketplace player in personal care for private-label production; announcing a Rs 33 crore expansion plan in February 2024 involving land acquisition, plant construction, and machinery procurement at its Vapi, Gujarat facility to achieve USFDA and WHO compliance; and targeting Rs 100 crore revenue within 2-3 years.